">
">
">
ADVERTISEMENT

COVID-19: Africa Urgently Requires 20 Million Oxford-AstraZeneca COVID-19 Vaccine Doses

">
ADVERTISEMENT

Africa requires at least 20 million Oxford-AstraZeneca COVID-19 vaccine doses in the next six weeks to enable the continent to deliver second shots to populations that received their first doses. World Health Organisation (WHO) regional official said on Thursday, My 27, 2021.

 

Matshidiso Moeti, WHO regional director for Africa, said during a virtual press briefing hosted by WHO Regional Office for Africa in Brazzaville, Republic of the Congo. Moeti added that the continent requires additional vaccine doses as a matter of urgency amid supply crunch that has stalled inoculation targeting high-risk groups.

“As supplies dry up, dose-sharing is an urgent, critical and short-term solution to ensuring that Africans at the greatest risk of COVID-19 get the much-needed protection,’’ Moeti said in a statement.

Statistics from Africa Centers for Disease Control and Prevention show that the continent has acquired 43.5 million vaccine doses and has administered 28.2 million as of Wednesday.

While saying that an additional 200 million doses of any of the WHO emergency use listed COVID-19 vaccines are needed to immunise 10 per cent of African population by September.

Moeti said that he believes that the urgency to vaccinate a critical mass of the African population is informed by emergence of highly contagious variants that threaten to overrun already fragile health system

">
">
ADVERTISEMENT

Related posts

Africa requires at least 20 million Oxford-AstraZeneca COVID-19 vaccine doses in the next six weeks to enable the continent to deliver second shots to populations that received their first doses. World Health Organisation (WHO) regional official said on Thursday, My 27, 2021.

 

Matshidiso Moeti, WHO regional director for Africa, said during a virtual press briefing hosted by WHO Regional Office for Africa in Brazzaville, Republic of the Congo. Moeti added that the continent requires additional vaccine doses as a matter of urgency amid supply crunch that has stalled inoculation targeting high-risk groups.

“As supplies dry up, dose-sharing is an urgent, critical and short-term solution to ensuring that Africans at the greatest risk of COVID-19 get the much-needed protection,’’ Moeti said in a statement.

Statistics from Africa Centers for Disease Control and Prevention show that the continent has acquired 43.5 million vaccine doses and has administered 28.2 million as of Wednesday.

While saying that an additional 200 million doses of any of the WHO emergency use listed COVID-19 vaccines are needed to immunise 10 per cent of African population by September.

Moeti said that he believes that the urgency to vaccinate a critical mass of the African population is informed by emergence of highly contagious variants that threaten to overrun already fragile health system

">
">
ADVERTISEMENT
Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.

Add New Playlist